Simultaneous acute shoulder arthritis and multiple mononeuropathy in a newly diagnosed type 2 diabetes patient – First case report by Kotlęga, Dariusz et al.
Case report
Simultaneous acute shoulder arthritis and multiple
mononeuropathy in a newly diagnosed type 2
diabetes patient – First case report
Dariusz Kotlęga a,b,*, Monika Gołąb-Janowska a, Grzegorz Zaborowski c,
Sylwester Ciećwież d, Przemysław Nowacki a
aDepartment of Neurology, Pomeranian Medical University in Szczecin, Szczecin, Poland
bAldemed Centrum Medyczne, Zielona Góra, Poland
cMagnetic Resonance Laboratory, Afﬁdea Lubuskie Centrum Medyczne, Zielona Góra, Poland
dDepartment of Gynaecology and Urogynaecology, Pomeranian Medical University, Szczecin, Poland
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 0 ( 2 0 1 6 ) 4 7 4 – 4 8 0
a r t i c l e i n f o
Article history:
Received 25 December 2015
Received in revised form
8 July 2016
Accepted 13 July 2016







a b s t r a c t
Diabetes is a common disorder that leads to the musculoskeletal symptoms such as the
shoulder arthritis. The involvement of peripheral nervous system is one of the troublesome
for the patients as it provokes chronic sensory symptoms, lower motor neuron involvement
and autonomic symptoms. In the course of the disease there has been several types of
neuropathies described.
A 41-year-old male patient was admitted to the internal medicine department because of
the general weakness, malaise, polydypsia and polyuria since several days. The initial blood
glucose level was 780 mg/dl. During the ﬁrst day the continuous insulin infusion was
administered. On the next day when he woke up, the severe pain in the right shoulder
with limited movement, right upper extremity weakness and burning pain in the radial
aspect of this extremity appeared. On examination right shoulder joint movement limitation
was found with the muscle weakness and sensory symptoms in the upper limbs. The clinical
picture indicated on the right shoulder arthritis and the peripheral nervous system symp-
toms such as the right musculocutaneous, supraspinatus, right radial nerve and left radial
nerve damage.
We present a ﬁrst case report of simultaneous, acute involvement of the shoulder joint
and multiple neuropathy in a patient with newly diagnosed type 2 diabetes, presumably in
the state of ketoacidosis.
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In the diabetic patients there is higher risk of musculoskeletal
symptoms, such as the shoulder arthritis called ‘‘frozen
shoulder’’ that is an orthopedic disorder connected with the
presence of diabetes. The frequency in diabetic patients ranges
from 6.7% to 31.8%, while in non-diabetics is observed in 2–3%
[1,2]. There is a strong association between risk of shoulder
capsulitis (SC) and the duration of diabetes. In diabetic patients
it is also more often bilateral. There has been shown
correlation between SC and microvascular complications such
as retinopathy and autonomic neuropathy [3].
The musculoskeletal complications in diabetes result from
prolonged hyperglycemia that activates two metabolic cas-
cades: enzymatic (throughout aldolase reductase) and non-
enzymatic (throughout glication). Non-enzymatic glication of
type IV colagen leads to increase of arterial resistance that
decreases tissue perfusion and causes nerve hypoxia [2].
The diabetic neuropathy contains several types of clinical
manifestations. The pathogenesis is linked to hyperglycemia
and subsequent metabolic and ischemic changes, but also
compressive and inﬂammatory etiology is proposed. The most
common type of diabetic neuropathy is symmetrical, distal,
sensorimotor polyneuropathy. Other types of diabetic neu-
ropathy include lumbosacral radiculoplexus neuropathy (dia-
betic cachexia), neuropathies with involvement of trunk,
cranial nerves, mononeuropathies and autonomic neuropa-
thy. There are also distinct types of neuropathies such as
‘‘neuropathy after ketoacidosis’’ and diabetic radiculoplexus
neuropathies (DRPN). The DRPN neuropathies consist of
diabetic cervical radiculoplexus neuropathy (DCRPN), diabetic
thoracic radiculoneuropathy (DTR) and diabetic lumbosacral
radiculoplexus neuropathy (DLRPN) [4].
There has been only 2 patients presented with SC and
neuropathy as a cervical radiculopathy [5]. To our knowledge
there has not been presented cases with an acute, simulta-
neous shoulder inﬂammation and multiple mononeuropathy
in the new onset diabetic patient with ketoacidosis.
Case presentation
A male, 41-year old Caucasian patient was admitted to the
internal medicine department in the west part of Poland,Table 1 – Initial blood and urine laboratory test results.
Parameter Result 
1. Creatinine 1.58 mg/dl 
2. Urea 44.5 mg/dl 
3. Natrium 132.8 mmol/l 
4. Potassium 5.5 mmol/l 
5. Glucose 678.22 mg/dl 
6. Alanine aminotranferase 215.84 U/l 
7. Aspartate aminotransferase 104.77 U/l 
8. TSH 1.28 uIU/ml 
9. Triglycerides 311 mg/dl 
10. LDL cholesterol 67.4 mg/dl because of high blood glucose level (780 mg/dl) detected by the
general practitioner. The measurement was performed be-
cause of general weakness, malaise, polydypsia and polyuria
that had been present for several days before. The initial
laboratory results are listed in Table 1, the BMI was 28.5. During
the ﬁrst day after admission he was on the insulin pump with
continuous insulin infusion. Till the next morning the blood
glucose level of 200 mg/dl was reached and insulin infusion
terminated. At this time, new symptoms appeared, such as the
severe pain in the right shoulder with limited movement, right
upper extremity weakness and burning pain within the radial
aspect of this extremity. The exact time of the onset is not
known, because patient woke up with these symptoms. After
7 days the weakness of left arm was noticed. There was
number of additional tests performed. The abdominal ultra-
sonography showed moderate hepatic steatosis. The brain MRI
detected bilaterally multifocal leukodystrophic lesions in the
deep white matter. Other tests showed no abnormalities:
cervical spine CT, the X-ray and ultrasonography of right
shoulder, the right upper extremity Doppler ultrasonography.
The concomitant medical history included hypertension and
previous, distant glomerulonephritis. The orthopedics, rheu-
matologist and neurologist consultations were made, without
establishing any diagnosis. After 1 week patient was sent
home with drugs prescribed, including insulin and with advice
to undergo further neurological diagnostics.
One month later patient visited the neurology outpatient
clinic. The main complaints were pain with movement
limitation in the right shoulder, weakness of the distal parts
of the upper extremities with predominance on the right,
burning pain radiating throughout radial aspect of the right
upper extremity. On examination: muscle wasting in the right
upper extremity within supraspinatus, subscapularis, teres
major, brachial muscles, almost immobile right shoulder joint
with 208 abduction, 308 ﬂexion and 308 extension (Fig. 1).
Muscle strength in the right elbow joint was decreased in the
ﬂexion movement. The strength in the right upper extremity
girdle was difﬁcult to assess, because of the severe passive and
active movement limitation. There was also severe pain while
shoulder movement. Flexion of the right wrist was 2 points in
MRC (Medical Research Council) scale, extension 1 point.
Decreased sensation of the radial aspect of right forearm and
wrist was found. In the left upper extremity there was
weakness of the wrist extension of 2 points MRC scale and
decreased sensation over the skin area between the thumbParameter Result
11. CRP 12.98 mg/l
12. pH 7.36
13. PCO2 29.4 mmHg
14. HCO3
 16.2 mmol/l
15. Urine density 1.015
16. Urine pH 5.5
17. Urine glucose 2014 mg/dl
18. C-peptide 3.56 ng/ml
19. Insulin 3.3 uIU/ml
20. HbA1c 15.8%
Fig. 1 – The image of a patient presenting the range of
abduction movement.
Fig. 3 – The MRI of right shoulder (STIR).
Fig. 4 – The MRI of right shoulder (T1).
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100 mg once daily and amitriptyline 50 mg once daily were
prescribed, rehabilitation was advised.
During the outpatient elective diagnostics, the nerve
conduction studies and MRI of right shoulder joint were
performed 14 weeks after the onset of the symptoms. The
shoulder MRI showed ﬂuid in the tendon of biceps muscle and
small amount in the joint capsule (Figs. 2 and 3), as well as
thickened and heterogeneously increased density in the
tendon of supraspinatus muscle (Fig. 4). The initial motor
and nerve conduction study showed multifocal damage of the
peripheral nervous system i.e. right musculocutaneous, right
suprascapular nerves and left radial nerve (Tables 2 and 3).
Right radial nerve was not tested at that time, but clinical
picture indicated also on right radial nerve damage. The
muscle records were not performed.
Patient was controlled at week 18 since the onset with
gradual improvement of shoulder joint mobility, slight
improvement in the muscle strength and sensory symptoms.
He was undergoing rehabilitation and was taking prescribedFig. 2 – The MRI of right shoulder (PD FS).drugs. Patient was referred to an orthopedics because of the
right shoulder joint inﬂammation.
Next visit took place 6 months after the onset. The MRI of
the right brachial plexus made 6 months after the onset was
normal. Patient was not qualiﬁed for the surgical treatment.
Gradual improvement of right shoulder mobility and muscle
strength were achieved following the continuous rehabilita-
tion. The shoulder joint was no longer painful. Neuralgic pain
exacerbated on the radial aspect of the right forearm and wrist,
sensation in the right arm came to normal. Diclofenac 75 mg
twice daily and venlafaxin 75 mg once daily were prescribed
instead of ketoprofen and amitriptyline. 16 months since the
onset almost full motion range in the right shoulder joint was
restored, the muscle strength signiﬁcantly improved with the
strength of 4 points MRC in the right wrist extension and 3
points on the left. The painful paresthesias resolved with only
the hyposthesia persistent on the right side. The follow-up
neurological examination was consistent with the
electrophysiological studies that are presented in Tables 2–4.
Discussion
We presented a simultaneous onset of the right shoulder joint
inﬂammation and multifocal mononeuropathy during the
intensive insulin treatment of severe hyperglycemia in the
Table 2 – Sensory nerve conduction study.
Nerve/site Record number (I-initial, II-follow-up) Latency (ms) Peak amplitude (uV) Velocity (m/s)
Left median – digit II (palm) I 2.55 8.6 47.8
II 3.13 8.4 51.0
Left median – digit II (palm) I NT NT NT
II 3.01 1.74 52.5
Left ulnar – digit V (wrist) I 2.3 4.1 44.3
II 3.0 3.4 46.1
Right ulnar – digit V (wrist) I 2.1 6 47.6
II 2.61 4.7 53.5
Left radial – thumb (forearm) I 2.3 6.6 52.2
II 2.0 3.2 52.4
Right radial – thumb (forearm) I NT NT NT
II – – –
NT, not tested; –, no response.









Left median (wrist) I 2.8 13
II 3.63 10.6
Left median (elbow) I 8.15 12.7 52.3
II 8.75 10.6 47.9
Left median (axilla) I 10.95 12.7 57.1
II 10.1 10.8 59.3
Right median (wrist) I 2.8 7.6
II 3.37 9.7
Right median (elbow) I 7.85 7.8 52.5
II 8.18 9.6 49.9
Right median (axilla) I 11.35 6.5 50
II 9.50 9.5 53
Left ulnar (wrist) I 2.35 9.7
II 2.71 14.2
Left ulnar (elbow) I 7.65 7.2 55.7
II 7.92 12.8 43.2
Left ulnar (axilla) I 11.7 6 59.3
II 9.47 12.9 51.6
Right ulnar (wrist) I 2.15 6.3
II 2.73 11.5
Right ulnar (elbow) I 7.2 6.5 55.4
II 6.87 10.7 53.1
Right ulnar (axilla) I 12.1 7.8 49
II 9.22 10.4 57.7
Left radial (forearm) I 1.6 1.1
II – –
Left radial (upper arm) I 4.25 2 45.3
II – – –
Right radial (forearm) I NT NT
II 1.76 11.0
Right radial I NT NT NT
II 4.65 11.8 48.1
Right radial I NT NT NT
II 6.02 12.7 74.5
Right musculocutaneous – biceps (axilla) I 1.8 1.1
II NT NT
Right musculocutaneous – biceps (EP) I 6.05 2 45.5
II 4.23 6.0
Right suprascapularis – infrascapularis,
supraspinatus (EP – Infraspinatus)
I 2.6 1 46.4
II 2.03 6.6
NT, not tested; –, no response.
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Table 4 – F wave records.
Nerve/site F wave minimal latency (ms) Persistence (%)
Left median (wrist – abductor pollicis brevis) 24.6 100
Right median (wrist – abductor pollicis brevis) 24.9 91.7
Right peroneal II (ankle – extensor digitorum brevis) 56.9 43.8
Right tibial (ankle – abductor hallucis) 59.7 100
Left ulnar (wrist – abductor minimi digiti) 25.2 100
Right ulnar (wrist – abductor minimi digiti) 25.4 100
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made, but the clinical symptoms and other laboratory tests
indicate on mild ketoacidosis state. The peripheral nervous
system symptoms involved right musculocutaneous, supras-
pinatus, right radial nerve and left radial nerve damage. The
limitation of our description is the fact, that initial muscle and
extended nerve conduction studies were not performed. The
follow-up electrophysiological studies indicated on the im-
provement in right suprascapular and musculocutaneous
nerves, persistent damage to right radial nerve (initially
detected only in physical examination, no electrophysiological
testing was performed) and worsening within the left radial
nerve. The minimal F wave latency records in the upper limbs
were within the normal range, whereas in the lower limbs
there was a prolonged latency and decreased persistence
detected suggesting the spinal radiculopathy. The coincidence
of chronic neuropathy with diabetes is common, but in a
presented case the symptoms appeared with accompanying
shoulder joint symptoms, suddenly, during the rapid hypogly-
cemic therapy of mild ketoacidosis in a newly diagnosed
diabetes. To our knowledge, such a characteristics of symp-
toms in described for the ﬁrst time.
The patients with a diabetic ketoacidosis and an acute
neuropathy, but without shoulder joint involvement were
reported. There is a case report when 1 week after the
introduction of oral hypoglycemic treatment in a newly
diagnosed diabetic patient sudden neuropathy symptoms
appeared. The initial blood glucose level was 381 mg/dl. The
peripheral nerve symptoms were axonal axillary and muscu-
locutaneous neuropathy on the right side and panplexopathy
on the left, with bilateral moderate to severe muscle weakness
and mild hypoaesthesia. Of note may be the concomitant
medical history with previous poliomyelitis and previously
present polyneuropathy of lower extremities [6]. In a case
report there was bilateral brachial plexopathy described
during the diabetic ketoacidosis and intensive insulin treat-
ment. A patient described with an acute brachial plexopathy
associated with diabetic ketoacidosis had initial blood glucose
level of 700 mg/dl with no previous history of diabetes. The
symptoms of brachial plexus damage appeared 2 days after
the onset of ketoacidosis [7].
Another case report described a patient with 13-year-
history and well controlled type 2 diabetes on insulin therapy
for 5 preceding years. The onset of the symptoms was not
acute, but gradual with progressive left arm weakness that
evolved for more than 3 months after the onset of pain and
stabilized thereafter. Right arm weakness developed over the
preceding 3 months and has continued to progress. Electro-
myography and nerve conduction studies revealed bilateralupper-trunk brachial plexopathy [8]. There are important
differences between this and our patient within the gradual
onset of the symptoms, previous chronic treatment of diabetes
and distribution of neuropathy.
There is a case report of a newly onset type 1 diabetes with
blood glucose level of 629 mg/dl, subsequent ketoacidosis and
mononeuropathy of peroneal nerve [9]. Another patient with
de novo type 1 diabetes in diabetic ketoacidosis developed
simultaneous intracerebral hemorrhage with the left ulnar
nerve palsy, ulnar, median, and radial nerve palsies on the
right on day 7 since the diabetic ketoacidosis and comatose
state for ﬁrst the 24 h [10]. Another patient – 10-year-old girl
was diagnosed of de novo type 1 diabetes with the initial blood
glucose level of 629 mg/dl and the electrophysiological study
indicating on a lesion of the peroneal nerve [11]. In a 9-year-old
boy with newly diagnosed type 1 diabetes and ketoacidosis the
acute peripheral nervous system damage was noticed i.e.
complete lesion of the right radial, the left common peroneal
nerves and partial lesion of the right common peroneal and
sural nerves [12].
There has been only 2 cases reported with simultaneous
shoulder arthritis and neuropathy in a diabetic patient. In a
ﬁrst case the left arm weakness with left shoulder movement
limitation were demonstrated 3 months after type 2 diabetes
diagnosis and oral hypoglycemic agent were introduced. The
radiographic and clinical diagnosis of shoulder capsulitis was
made with C5 radiculopathy on the left side, which was not
resulting from spine pathology. The second patient had
previous history of type 2 diabetes with oral hypoglycemic
drugs and C5 radiculopathy on the right with ipsilateral
shoulder capsulitis. There is no available information if the
symptoms had chronic or acute onset [5].
There is a question raised, what may be the mechanism of
such an acute, diffused damage to the peripheral nervous
system. The diabetic neuropathy is proved as a consequence of
metabolic changes including polyol pathway ﬂux, increased
advanced glycosylation, elevated oxidative stress and im-
paired fatty acid metabolism [13]. Diabetic ketoacidosis is a
proinﬂammatory condition with vascular endothelial pertur-
bation and dysregulation of the coagulation system features
associated with abnormal levels and activities of several
coagulation factors, including platelets, which result in a
procoagulant state. Additional factors contributing to the
procoagulant state are abnormalities in blood volume, blood
viscosity, cerebral autoregulation and blood ﬂow, while
vascular injury may be a result of oxidative injury and
ischemia related to systemic hypoperfusion, vascular dysre-
gulation, or cerebral edema [14]. The neurological impairment
may be connected with the functional neural lesions due to
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immune system response in generating the neuropathy may
be suggested on the basis of two patients with a Guillain-Barre
syndrome developed just after treating the ketoacidosic
comatose state in new onset diabetes [15]. The pathogenesis
of DLRPN is the ischemic injury caused by vasculitis [16].
Another explanation may be the neuronal damage due to
hyperglycemia metabolic effects, such as metabolic acidosis,
hyperosmolality, dehydration or electrolyte imbalance [17]. It
is also possible that both ischemic and inﬂammatory compo-
nent is involved in this process. The nerve biopsy in DCRPN
shows ischemic injury and increased inﬂammation [18]. The
immune system activation play the key role in the LADA
diabetes (Latent Autoimmune Diabetes of Adults), but in our
patient the diagnosis of type 2 diabetes was established [19].
An explanation of the simultaneous shoulder joint inﬂam-
mation with neuropathy is not clear. The most convincing
pathogenetic background may be the metabolic effects or
inﬂammation. In a biopsy-based study of the elderly diabetic
neuropathy patients, authors suggested that the pathogenesis
is related to the pre-capillary blood vessel involvement with a
secondary inﬂammatory response [20]. Inﬂammatory agents
may play role in the neuropathy and shoulder arthritis. Other
explanation is also possible, especially that in the SC patients
the neuronal proteins expression is increased and new nerve
ﬁbers are found. There was demonstrated increased expres-
sion of the nerve growth factor receptor p75 and CD34 – an
endothelial cell marker, thenprotein gene product 9.5 (PGP9.5)
– general nerve marker and the growth associated protein 43
(GAP43) that is a nerve growth marker. These results indicate
on neoinnervation and neoangiogenesis in SC, which may be
essential for explanation the pathogenesis of simultaneous
joint and nerve damage [21].
Another issue is to establish the type of neuropathy in
terms of lesion distribution. Symptoms observed in our patient
suits the most to the ‘‘neuropathy after ketoacidosis’’ which is
very rare condition with clinical picture of multiple mono-
neuropathies [4]. Less likely there might be the diagnosis of
DCRPN which leads to moderate motoric deﬁcits with
improvement at follow-up. Upper, middle and lower brachial
plexus segments are involved equally and over half of patients
had at least one additional body region affected (contralateral
cervical, lumbosacral, thoracic or less common isolated
peripheral nerve alone) [18].
Presented case was the ﬁrst patient with simultaneous
multiple mononeuropathy, probably the ‘‘neuropathy after
ketoacidosis’’ type and shoulder arthritis. Biopsy studies
would be useful to unearth the pathogenesis, which was not
performed as well as extended initial electrophysiological
studies, but there were the follow-up electrophysiological
records performed 16 months since the onset that conﬁrmed
clinical diagnosis. Our description may be important in further
studies in the ﬁeld of diabetic neuropathy and joint involve-
ment in diabetics. Such an unusual presentation has also the
educational value for neurologists.
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